415 Capital
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
- Israel
Investment stages
- Series A
Industries
- Fintech
- AI
- Health Tech
About
415 Capital is a specialized venture Capital firm based in Munich, Germany. The firm focuses on investing in early and developmentstage medical Technology companies across Europe, Israel, and the US. 415 Capital is dedicated to supporting breakthrough and lifesaving medical device technologies, targeting large unmet needs in chronic diseases with a focus on cardio and neurovascular disorders.
415 Capital is a specialized venture Capital firm based in Munich, Germany. The firm focuses on investing in early and developmentstage medical Technology companies across Europe, Israel, and the US. 415 Capital is dedicated to supporting breakthrough and lifesaving medical device technologies, targeting large unmet needs in chronic diseases with a focus on cardio and neurovascular disorders.
Investment Thesis
415 Capital invests in innovative medical technologies that address significant unmet needs in chronic diseases, particularly in cardiovascular and neurovascular areas, which are leading causes of death and major cost drivers in global healthcare systems. The firm's approach involves identifying and nurturing technologies that have the potential to revolutionize treatment and improve patient outcomes.
Portfolio
Laza Medical
Supira MediMoray Medical
CorFlow Therapeutics
Cardiac Success
Aktiia
Distalmotion
TRiCares.